From high doses of oral rivastigmine to transdermal rivastigmine patches: user experience and satisfaction among caregivers of patients with mild to moderate Alzheimer disease

Statistics

Original article

Experiencia de uso y satisfacción con rivastigmina transdérmica en cuidadores de pacientes con enfermedad de Alzheimer de leve a moderada previamente tratados con rivastigmina oral a dosis altas

R. Reñéa,

Corresponding author

udtd@bellvitgehospital.cat

Corresponding author.

, J. Ricartb, B. Hernándezb, representing researchers in the Experience study

a Unidad de Diagnóstico y Tratamiento de las Demencias, Servicio de Neurología, Hospital Universitario de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain

b Departamento Médico, Novartis Farmacéutica, S.A., Barcelona, Spain

Read

6132

Times
was read the article

1281

Total PDF

4851

Total HTML

Share statistics

Article information

ISSN: 21735808
Original language: English

DOI:10.1016/j.nrleng.2013.12.004

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 12	137	5	142
2025 11	369	25	394
2025 10	104	9	113
2025 9	90	25	115
2025 8	88	14	102
2025 7	114	12	126
2025 6	134	7	141
2025 5	106	6	112
2025 4	52	7	59
2025 3	59	3	62
2025 2	56	10	66
2025 1	45	3	48
2024 12	45	4	49
2024 11	49	7	56
2024 10	27	8	35
2024 9	28	9	37
2024 8	48	7	55
2024 7	29	4	33
2024 6	51	7	58
2024 5	25	9	34
2024 4	58	14	72
2024 3	67	13	80
2024 2	71	20	91
2024 1	55	7	62
2023 12	72	15	87
2023 11	55	9	64
2023 10	53	13	66
2023 9	22	5	27
2023 8	26	14	40
2023 7	13	11	24
2023 6	28	9	37
2023 5	57	4	61
2023 4	40	4	44
2023 3	37	13	50
2023 2	17	5	22
2023 1	9	11	20
2022 12	31	8	39
2022 11	25	8	33
2022 10	30	12	42
2022 9	52	7	59
2022 8	47	25	72
2022 7	21	5	26
2022 6	23	11	34
2022 5	21	15	36
2022 4	31	13	44
2022 3	32	7	39
2022 2	28	15	43
2022 1	15	7	22
2021 12	20	18	38
2021 11	38	12	50
2021 10	23	10	33
2021 9	17	16	33
2021 8	19	7	26
2021 7	14	9	23
2021 6	19	8	27
2021 5	18	7	25
2021 4	30	10	40
2021 3	36	10	46
2021 2	12	3	15
2021 1	13	9	22
2020 12	21	12	33
2020 11	14	9	23
2020 10	16	10	26
2020 9	15	11	26
2020 8	17	11	28
2020 7	20	12	32
2020 6	15	6	21
2020 5	23	18	41
2020 4	14	5	19
2020 3	25	3	28
2020 2	13	4	17
2020 1	14	6	20
2019 12	32	7	39
2019 11	11	3	14
2019 10	18	5	23
2019 9	17	1	18
2019 8	11	3	14
2019 7	20	16	36
2019 6	40	13	53
2019 5	99	9	108
2019 4	67	4	71
2019 3	11	4	15
2019 2	17	7	24
2019 1	8	5	13
2018 12	11	2	13
2018 11	18	10	28
2018 10	28	7	35
2018 9	29	10	39
2018 8	11	4	15
2018 7	4	9	13
2018 6	9	6	15
2018 5	13	3	16
2018 4	17	9	26
2018 3	7	4	11
2018 2	5	1	6
2018 1	11	4	15
2017 12	11	1	12
2017 11	15	5	20
2017 10	11	4	15
2017 9	10	5	15
2017 8	17	9	26
2017 7	13	1	14
2017 6	49	10	59
2017 5	26	2	28
2017 4	6	3	9
2017 3	10	26	36
2017 2	13	2	15
2017 1	13	2	15
2016 12	17	9	26
2016 11	22	5	27
2016 10	24	11	35
2016 9	31	7	38
2016 8	31	5	36
2016 7	23	7	30
2016 6	28	10	38
2016 5	17	18	35
2016 4	24	14	38
2016 3	29	20	49
2016 2	21	8	29
2016 1	12	2	14
2015 12	14	5	19
2015 11	25	5	30
2015 10	23	8	31
2015 9	31	9	40
2015 8	17	5	22
2015 7	19	13	32
2015 6	12	13	25
2015 5	23	13	36
2015 4	30	17	47
2015 3	30	13	43
2015 2	32	6	38
2015 1	37	8	45
2014 12	65	8	73
2014 11	37	5	42
2014 10	47	11	58
2014 9	58	10	68
2014 8	39	9	48
2014 7	36	17	53
2014 6	34	12	46
2014 5	31	13	44
2014 4	33	20	53
2014 3	33	22	55

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter